You must log in to view this page.

Larimar Therapeutics Inc. – Filings and Transcripts

NASDAQ: LRMR
Share price (8/6/26): $4.20
Market cap (8/6/26): $436 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Hamilton Thomas Edward

Deerfield Management Company, L.P., Flynn James E

Leff Jonathan S

Sherman Jeffrey W

News Filter

Reports Second Quarter 2026 Financial and Business Update

Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Shareholder Vote Results

Reports First Quarter 2026 Financial and Business Update

Reports Fourth Quarter and Full Year 2025 Financial Results

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC